Latest / Bloomberg Law / J&J Challenges Talc Verdicts Across the Country (Audio)
Transcript
- 0:00Speaker 1: Jay and Jay has won a reversal of a seventy
- 0:02Speaker 1: two million dollar verdict claiming its talent products caused ovarian cancer.
- 0:07Speaker 1: It was the first of a series of jury awards
- 0:09Speaker 1: against J and J and a St. Louis court, and
- 0:11Speaker 1: it throws the fate of more than three hundred million
- 0:14Speaker 1: dollars in other awards in the same court into question,
- 0:17Speaker 1: as well as more than one thousand similar lawsuits filed there.
- 0:21Speaker 1: The lawsuit was filed by an Alabama woman before her
- 0:24Speaker 1: death in fifteen, and the Missouri Federal Appeals Court cited
- 0:27Speaker 1: a Supreme Court decision in June limiting out of state
- 0:31Speaker 1: plaintiffs from combining actions in a lower court. Joining us
- 0:35Speaker 1: is Howard Ericson, a professor at Fordham Law School who
- 0:37Speaker 1: specializes in complex litigation. Howard explained why the Missouri Appeals
- 0:43Speaker 1: Court throughout the award. Sure the U. S. Supreme Court
- 0:48Speaker 1: in June decided a case involving an entirely different drug
- 0:53Speaker 1: um but where the Supreme Court addressed the issue of
- 0:56Speaker 1: personal jurisdiction, that is, the power of a court debined
- 1:00Speaker 1: the defendant, and what the court said essentially is that
- 1:03Speaker 1: plaintiffs have to bring a lawsuit either in the defendant's
- 1:06Speaker 1: home state or in a state that the claim arose
- 1:11Speaker 1: out of. So in the Missouri talc case, you've got
- 1:14Speaker 1: an Alabama woman who had sued Johnson and Johnson, a
- 1:17Speaker 1: New Jersey company, in Missouri state court, and she was
- 1:22Speaker 1: able to do that initially because she joined her case
- 1:25Speaker 1: with a couple of Missouri plaintiffs as well as lots
- 1:28Speaker 1: of other plaintiffs from around the country. But based on
- 1:31Speaker 1: this new Supreme Court ruling, what the Missouri Appellate Court
- 1:34Speaker 1: had to say is, well, the Missouri State Court simply
- 1:37Speaker 1: doesn't have the power to render a decision in the
- 1:40Speaker 1: case in this case between an Alabama plaintiffs and a
- 1:44Speaker 1: New Jersey company, given that it's not the defendant's home
- 1:47Speaker 1: state and it's not a state that the claimer rose
- 1:49Speaker 1: out of. Well, clearly this decision has is meant to
- 1:54Speaker 1: try to stop some kind of forum shopping I've seen
- 1:56Speaker 1: by the Supreme Court where plainiffs lawyers try to pick a, uh,
- 2:00Speaker 1: you know, a favorable place to bring a particular lawsuit.
- 2:04Speaker 1: Was that the situation here? Why did they pick Missouri
- 2:06Speaker 1: as the place to file this case? Yeah, I think
- 2:09Speaker 1: you've said it exactly exactly right. That it's quite common
- 2:14Speaker 1: for lawyers representing plaintiffs to choose what they consider the
- 2:19Speaker 1: strategically most advantageous forum. And there's nothing wrong with that.
- 2:23Speaker 1: That's that's what every good plaintiffs lawyer ought to do.
- 2:26Speaker 1: And by the same token, every good defense lawyer should
- 2:30Speaker 1: try to decide is this a disadvantageous forum, and if so,
- 2:33Speaker 1: should see if there are procedural avenues to get the
- 2:36Speaker 1: case moved to a different forum. Um. But that is
- 2:40Speaker 1: the baseline that the Supreme Court was dealing with when
- 2:43Speaker 1: it decided to Bristol Myers Squib case in June. And
- 2:46Speaker 1: you're absolutely right. This limit on personal jurisdiction now makes
- 2:51Speaker 1: it more difficult for plaintiffs to choose the forum that
- 2:55Speaker 1: they consider strategically most advantageous. So, Howard, in four of
- 2:59Speaker 1: the five try was held so far in St. Louis,
- 3:01Speaker 1: the jurors awarded more than three hundred million dollars combined.
- 3:06Speaker 1: J and Jay has appealed those are those going to
- 3:09Speaker 1: fall the same way that this case? Phil. It seems
- 3:13Speaker 1: to me quite likely that in the that in cases
- 3:17Speaker 1: On brought him a half of plaintiffs who are not
- 3:21Speaker 1: Missouri plaintiffs. And I believe all of those trials so
- 3:24Speaker 1: far where non Missouri plaintiffs that they're going to see
- 3:27Speaker 1: the same thing happened that the court is going to say, Uh,
- 3:30Speaker 1: Missouri does not have jurisdiction over Johnson and Johnson and
- 3:34Speaker 1: New Jersey Company in those cases and what happened, well,
- 3:40Speaker 1: then then the plaintiffs have the option of filing of
- 3:45Speaker 1: refiling the case either in the plaintiffs home state or
- 3:47Speaker 1: some other states that the claimer rose out of, perhaps
- 3:50Speaker 1: where they bought the product or used the product, or
- 3:52Speaker 1: were injured by the product, or to take it to
- 3:55Speaker 1: Johnson and Johnson in J and J's home state of
- 3:58Speaker 1: New Jersey. So hour you have J and J facing
- 4:02Speaker 1: more than dal claims in state and federal courts in
- 4:07Speaker 1: the US. How has it been faring well so far?
- 4:12Speaker 1: Not so not so good. I mean, the most of
- 4:16Speaker 1: the trials had come out and plaintive favor, but of
- 4:19Speaker 1: course most of those had been in Missouri. And this
- 4:23Speaker 1: change in the forum shopping regime is um is a
- 4:27Speaker 1: real plus for Johnson and Johnson. But the big news
- 4:33Speaker 1: at the end of the summer was the California verdict
- 4:35Speaker 1: in atcha area where J and J was hit with
- 4:38Speaker 1: a four seventeen million dollar verdict in a California case.
- 4:42Speaker 1: The company is now trying to get that overturned m
- 4:46Speaker 1: and they've asked the court to either to grant judgment
- 4:50Speaker 1: as a matter of law or a new trial, and
- 4:52Speaker 1: that ought to be decided quite soon. You know. They've
- 4:55Speaker 1: been one of the ways in which j J is
- 4:57Speaker 1: attacking these cases. They're saying that although there's some scientific
- 5:00Speaker 1: evidence that's been put in that it doesn't really back
- 5:02Speaker 1: up the claim at all that the Talcolm powder has
- 5:07Speaker 1: a link to a varying cancer. How are courts treating
- 5:10Speaker 1: their legal argument about the strength of the evidence. It's
- 5:14Speaker 1: actually been quite varied. There was a new Jersey court
- 5:17Speaker 1: that said they're simply isn't the scientific evidence to back
- 5:20Speaker 1: up the plaintiff's claims, and the court excluded the plaintiff's
- 5:25Speaker 1: scientific evidence of causation um. But these other courts in
- 5:29Speaker 1: Missouri and California have have treated it differently. This is
- 5:33Speaker 1: what happens when when lawsuits get out ahead of science.
- 5:38Speaker 1: Science has the luxury of moving step by step trying
- 5:43Speaker 1: to find truth, but courts don't have that luxury. They've
- 5:46Speaker 1: got a case between a plaint defendant defendant and actually
- 5:49Speaker 1: have to decide the case based on the science has
- 5:53Speaker 1: that as it is now, and in this case, you're right,
- 5:56Speaker 1: the science is quite undeveloped and very much in dispute.
- 6:02Speaker 1: So Howard, let's talk a little bit about this is
- 6:04Speaker 1: supposed to be a Bell bell Weather cases, so they
- 6:08Speaker 1: can decide which to settle, what settlement amounts might be.
- 6:11Speaker 1: How does it stand now with all these reversals, It
- 6:17Speaker 1: does pro things up in the air a bit june On.
- 6:20Speaker 1: You're you're right that when there are when there's mass
- 6:23Speaker 1: tourt litigation pending, thousands of cases that are related, the
- 6:27Speaker 1: courts schedule these individual trials with the hope that they
- 6:31Speaker 1: will be bell weathers, that that they will provide data
- 6:35Speaker 1: points jury verdicts that the parties can then use um
- 6:38Speaker 1: to set expectations in the hope that the parties can
- 6:41Speaker 1: then negotiate some sort of global settlement um. But I
- 6:45Speaker 1: do think that the risk of reversal in the cases
- 6:50Speaker 1: so far changes the whole Um bell Weather aspect of
- 6:53Speaker 1: this and makes these verdicts somewhat less valuable. It does
- 6:57Speaker 1: seem to make it harder for them to use them
- 6:59Speaker 1: as bell Weather cases. But might it sort of make
- 7:02Speaker 1: it easier for Johnson and Johnson to settle all the
- 7:06Speaker 1: cases on a more favorable one more favorable terms. Yes, yes,
- 7:14Speaker 1: And uncertainty is generally thought to be a good motivator
- 7:19Speaker 1: for settlement. So the very fact that um that the
- 7:24Speaker 1: outcome of these cases is somewhat uncertain at this point
- 7:27Speaker 1: strengthens J and J's position. All right, Howard, it's a
- 7:31Speaker 1: pleasure to have you back on the show. That's Howard Ericson.
- 7:34Speaker 1: He's a professor at Fordham Law School. He specializes in
- 7:37Speaker 1: complex litigation. That's it for the sedition of Bloomberg Law.
- 7:41Speaker 1: We'll be back tomorrow at would bum Wall Street time
- 7:43Speaker 1: thanks to our producer David Suckerman and our technical director
- 7:46Speaker 1: Chris try Comey. Carol Master comes up next with Bloomberg Markets,
- 7:50Speaker 1: and she's here to tell us a little bit about
- 7:51Speaker 1: what's going to happen where you talking about the fed
- 7:54Speaker 1: bag book, those headlines crossing the Bloomberg in just a moment.
- 7:57Speaker 1: And then we've got to talk about robots taking over
- 7:59Speaker 1: jobs on walls. Treat you better watch out too. I
- 8:02Speaker 1: know I have to figure out what to do if
- 8:04Speaker 1: anything happens with voices of robots. That's it. This is Bloomberg.
- 8:09Speaker 1: M